4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0000950170-24-029542
Director sold 2,092 shares at $45.69 ($95,583)
- Director gave up 1,408 shares (to pay taxes)
- Director acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GAROFALO ELIZABETH A. · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-08 | Exercise or conversion : show line 1 in the form | +3,500 | $18.56 | $64,960 | 3,500 | D |
| 2024-03-08 | Shares withheld for taxes : show line 2 in the form | −1,408 | $46.16 | $64,993 | 2,092 | D |
| 2024-03-08 | Sale : show line 3 in the form | −2,092 | $45.69 | $95,583 | 0 | D |
| Open-market sales · 2,092 sh · avg $45.69 · $95,583 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-03-08 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −3,500 | 16,500 | D |
Loading xslF345X05/ownership.xml…